{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:12:19Z","timestamp":1794654739888,"version":"4.9.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic neuroinflammation is a major obstacle to post-stroke recovery, yet the underlying mechanisms, particularly the link between prolonged microglial activation and cholesterol metabolism, are not fully known. Here we show that ischaemic injury induces persistent microglial activation that perpetuates chronic inflammation, leading to microglial cholesterol accumulation and metabolic reprogramming. Using single-cell RNA sequencing, we identified distinct stroke-associated foamy microglia clusters characterized by extensive reprogramming of cholesterol metabolism. Furthermore, direct intracerebral free cholesterol or cholesterol crystal infusion recapitulated sustained microglial activation, directly linking aberrant cholesterol metabolism to prolonged neuroinflammatory responses. Therapeutically, we demonstrate that reducing microglial cholesterol overload through genetic or pharmacological activation of CYP46A1 in male mice promotes white matter repair and functional recovery. These findings highlight microglial cholesterol metabolism as a key driver of post-stroke inflammation, offering therapeutic strategies targeting cholesterol metabolism to mitigate long-term brain damage and promote neurorestoration, potentially improving stroke-related disability outcomes.<\/jats:p>","DOI":"10.1038\/s42255-025-01379-7","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T09:08:54Z","timestamp":1758618534000},"page":"2099-2116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Cholesterol metabolic reprogramming mediates microglia-induced chronic neuroinflammation and hinders neurorestoration following stroke"],"prefix":"10.1038","volume":"7","author":[{"given":"Qiang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxue","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3075-5434","authenticated-orcid":false,"given":"Junwei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"key":"1379_CR1","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","volume":"359","author":"W Hacke","year":"2008","unstructured":"Hacke, W. et al. Thrombolysis with alteplase 3 to 4.5\u2009h after acute ischemic stroke. N. Engl. J. Med. 359, 1317\u20131329 (2008).","journal-title":"N. Engl. J. Med."},{"key":"1379_CR2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrneurol.2014.207","volume":"11","author":"X Hu","year":"2015","unstructured":"Hu, X. et al. Microglial and macrophage polarization\u2014new prospects for brain repair. Nat. Rev. Neurol. 11, 56\u201364 (2015).","journal-title":"Nat. Rev. Neurol."},{"key":"1379_CR3","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1212\/WNL.55.7.1052","volume":"55","author":"S Pappata","year":"2000","unstructured":"Pappata, S. et al. Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195. Neurology 55, 1052\u20131054 (2000).","journal-title":"Neurology"},{"key":"1379_CR4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.neuroimage.2004.09.034","volume":"24","author":"A Gerhard","year":"2005","unstructured":"Gerhard, A., Schwarz, J., Myers, R., Wise, R. & Banati, R. B. Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study. Neuroimage 24, 591\u2013595 (2005).","journal-title":"Neuroimage"},{"key":"1379_CR5","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S1474-4422(19)30078-X","volume":"18","author":"K Shi","year":"2019","unstructured":"Shi, K. et al. Global brain inflammation in stroke. Lancet Neurol. 18, 1058\u20131066 (2019).","journal-title":"Lancet Neurol."},{"key":"1379_CR6","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nn1426","volume":"8","author":"G Saher","year":"2005","unstructured":"Saher, G. et al. High cholesterol level is essential for myelin membrane growth. Nat. Neurosci. 8, 468\u2013475 (2005).","journal-title":"Nat. Neurosci."},{"key":"1379_CR7","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1161\/01.ATV.0000120374.59826.1b","volume":"24","author":"I Bj\u00f6rkhem","year":"2004","unstructured":"Bj\u00f6rkhem, I. & Meaney, S. Brain cholesterol: long secret life behind a barrier. Arterioscler. Thromb. Vasc. Biol. 24, 806\u2013815 (2004).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1379_CR8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1515\/BC.2009.035","volume":"390","author":"JM Dietschy","year":"2009","unstructured":"Dietschy, J. M. Central nervous system: cholesterol turnover, brain development and neurodegeneration. Biol. Chem. 390, 287\u2013293 (2009).","journal-title":"Biol. Chem."},{"key":"1379_CR9","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","volume":"45","author":"JM Dietschy","year":"2004","unstructured":"Dietschy, J. M. & Turley, S. D. Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J. Lipid Res. 45, 1375\u20131397 (2004).","journal-title":"J. Lipid Res."},{"key":"1379_CR10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.neuropharm.2017.06.026","volume":"123","author":"N Mast","year":"2017","unstructured":"Mast, N. et al. Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer\u2019s disease. Neuropharmacology 123, 465\u2013476 (2017).","journal-title":"Neuropharmacology"},{"key":"1379_CR11","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/awv384","volume":"139","author":"L Boussicault","year":"2016","unstructured":"Boussicault, L. et al. CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington\u2019s disease. Brain 139, 953\u2013970 (2016).","journal-title":"Brain"},{"key":"1379_CR12","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201948143","volume":"20","author":"DN Mitroi","year":"2019","unstructured":"Mitroi, D. N. et al. NPC1 enables cholesterol mobilization during long-term potentiation that can be restored in Niemann\u2013Pick disease type C by CYP46A1 activation. EMBO Rep. 20, e48143 (2019).","journal-title":"EMBO Rep."},{"key":"1379_CR13","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1074\/jbc.M113.532846","volume":"289","author":"N Mast","year":"2014","unstructured":"Mast, N. et al. Pharmacologic stimulation of cytochrome P450 46A1 and cerebral cholesterol turnover in mice. J. Biol. Chem. 289, 3529\u20133538 (2014).","journal-title":"J. Biol. Chem."},{"key":"1379_CR14","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa180","volume":"2","author":"N Mast","year":"2020","unstructured":"Mast, N., El-Darzi, N., Petrov, A. M., Li, Y. & Pikuleva, I. A. CYP46A1-dependent and independent effects of efavirenz treatment. Brain Commun. 2, fcaa180 (2020).","journal-title":"Brain Commun."},{"key":"1379_CR15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13195-022-01151-z","volume":"14","author":"AJ Lerner","year":"2022","unstructured":"Lerner, A. J. et al. CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer\u2019s disease. Alzheimers Res. Ther. 14, 198 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"1379_CR16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nri3793","volume":"15","author":"AR Tall","year":"2015","unstructured":"Tall, A. R. & Yvan-Charvet, L. Cholesterol, inflammation and innate immunity. Nat. Rev. Immunol. 15, 104\u2013116 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"1379_CR17","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41423-021-00670-3","volume":"18","author":"S Paik","year":"2021","unstructured":"Paik, S., Kim, J. K., Silwal, P., Sasakawa, C. & Jo, E. K. An update on the regulatory mechanisms of NLRP3 inflammasome activation. Cell Mol. Immunol. 18, 1141\u20131160 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"1379_CR18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s42255-024-01015-w","volume":"6","author":"C Stroope","year":"2024","unstructured":"Stroope, C. et al. Dysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunities. Nat. Metab. 6, 617\u2013638 (2024).","journal-title":"Nat. Metab."},{"key":"1379_CR19","doi-asserted-by":"crossref","first-page":"962","DOI":"10.2353\/ajpath.2007.070052","volume":"171","author":"G Liao","year":"2007","unstructured":"Liao, G. et al. Cholesterol accumulation is associated with lysosomal dysfunction and autophagic stress in Npc1\u2212\/\u2212 mouse brain. Am. J. Pathol. 171, 962\u2013975 (2007).","journal-title":"Am. J. Pathol."},{"key":"1379_CR20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.immuni.2019.11.015","volume":"52","author":"J Xiao","year":"2020","unstructured":"Xiao, J. et al. Targeting 7-dehydrocholesterol reductase integrates cholesterol metabolism and IRF3 activation to eliminate infection. Immunity 52, 109\u2013122.e106 (2020).","journal-title":"Immunity"},{"key":"1379_CR21","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature04399","volume":"438","author":"FR Maxfield","year":"2005","unstructured":"Maxfield, F. R. & Tabas, I. Role of cholesterol and lipid organization in disease. Nature 438, 612\u2013621 (2005).","journal-title":"Nature"},{"key":"1379_CR22","volume":"1866","author":"C Halkias","year":"2021","unstructured":"Halkias, C. et al. An advanced method for quantitative measurements of cholesterol crystallization. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1866, 158872 (2021).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"1379_CR23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0022-2275(20)40131-2","volume":"35","author":"RK Tangirala","year":"1994","unstructured":"Tangirala, R. K. et al. Formation of cholesterol monohydrate crystals in macrophage-derived foam cells. J. Lipid Res. 35, 93\u2013104 (1994).","journal-title":"J. Lipid Res."},{"key":"1379_CR24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/path.4873","volume":"241","author":"B Ho-Tin-No\u00e9","year":"2017","unstructured":"Ho-Tin-No\u00e9, B. et al. Cholesterol crystallization in human atherosclerosis is triggered in smooth muscle cells during the transition from fatty streak to fibroatheroma. J. Pathol. 241, 671\u2013682 (2017).","journal-title":"J. Pathol."},{"key":"1379_CR25","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01186-z","volume":"8","author":"Y Baumer","year":"2017","unstructured":"Baumer, Y. et al. Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis. Nat. Commun. 8, 1129 (2017).","journal-title":"Nat. Commun."},{"key":"1379_CR26","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41593-022-01022-8","volume":"25","author":"SE Marsh","year":"2022","unstructured":"Marsh, S. E. et al. Dissection of artifactual and confounding glial signatures by single-cell sequencing of mouse and human brain. Nat. Neurosci. 25, 306\u2013316 (2022).","journal-title":"Nat. Neurosci."},{"key":"1379_CR27","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s13311-019-00731-6","volume":"16","author":"AM Petrov","year":"2019","unstructured":"Petrov, A. M. & Pikuleva, I. A. Cholesterol 24-hydroxylation by CYP46A1: benefits of modulation for brain diseases. Neurotherapeutics 16, 635\u2013648 (2019).","journal-title":"Neurotherapeutics"},{"key":"1379_CR28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pharmthera.2018.09.003","volume":"194","author":"TR Guilarte","year":"2019","unstructured":"Guilarte, T. R. TSPO in diverse CNS pathologies and psychiatric disease: a critical review and a way forward. Pharm. Ther. 194, 44\u201358 (2019).","journal-title":"Pharm. Ther."},{"key":"1379_CR29","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3233\/JAD-200136","volume":"77","author":"BB Tournier","year":"2020","unstructured":"Tournier, B. B. et al. Astrocytic TSPO upregulation appears before microglial TSPO in Alzheimer\u2019s disease. J. Alzheimers Dis. 77, 1043\u20131056 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"1379_CR30","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/jcbfm.2009.205","volume":"30","author":"A Mart\u00edn","year":"2010","unstructured":"Mart\u00edn, A. et al. Evaluation of the PBR\/TSPO radioligand [18F]DPA-714 in a rat model of focal cerebral ischemia. J. Cereb. Blood Flow. Metab. 30, 230\u2013241 (2010).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"1379_CR31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.nbd.2018.01.007","volume":"112","author":"JC Zbesko","year":"2018","unstructured":"Zbesko, J. C. et al. Glial scars are permeable to the neurotoxic environment of chronic stroke infarcts. Neurobiol. Dis. 112, 63\u201378 (2018).","journal-title":"Neurobiol. Dis."},{"key":"1379_CR32","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.nurt.2010.05.014","volume":"7","author":"ME Lull","year":"2010","unstructured":"Lull, M. E. & Block, M. L. Microglial activation and chronic neurodegeneration. Neurotherapeutics 7, 354\u2013365 (2010).","journal-title":"Neurotherapeutics"},{"key":"1379_CR33","first-page":"792","volume":"140","author":"Z Fan","year":"2017","unstructured":"Fan, Z., Brooks, D. J., Okello, A. & Edison, P. An early and late peak in microglial activation in Alzheimer\u2019s disease trajectory. Brain 140, 792\u2013803 (2017).","journal-title":"Brain"},{"key":"1379_CR34","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/brain\/aww017","volume":"139","author":"L Hamelin","year":"2016","unstructured":"Hamelin, L. et al. Early and protective microglial activation in Alzheimer\u2019s disease: a prospective study using 18F-DPA-714 PET imaging. Brain 139, 1252\u20131264 (2016).","journal-title":"Brain"},{"key":"1379_CR35","doi-asserted-by":"crossref","first-page":"e2306863","DOI":"10.1002\/advs.202306863","volume":"11","author":"W Wei","year":"2024","unstructured":"Wei, W. et al. Dynamic brain lipid profiles modulate microglial lipid droplet accumulation and inflammation under ischemic conditions in mice. Adv. Sci. 11, e2306863 (2024).","journal-title":"Adv. Sci."},{"key":"1379_CR36","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108237","volume":"240","author":"M John Chapman","year":"2022","unstructured":"John Chapman, M. & Preston Mason, R. Cholesterol crystals and atherosclerotic plaque instability: therapeutic potential of eicosapentaenoic acid. Pharm. Ther. 240, 108237 (2022).","journal-title":"Pharm. Ther."},{"key":"1379_CR37","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1172\/JCI0216452","volume":"110","author":"I Tabas","year":"2002","unstructured":"Tabas, I. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J. Clin. Invest. 110, 905\u2013911 (2002).","journal-title":"J. Clin. Invest."},{"key":"1379_CR38","first-page":"389","volume":"16","author":"M B\u00e4ck","year":"2019","unstructured":"B\u00e4ck, M., Yurdagul, A. Jr., Tabas, I., \u00d6\u00f6rni, K. & Kovanen, P. T. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat. Rev. Cardiol. 16, 389\u2013406 (2019).","journal-title":"Nat. Rev. Cardiol."},{"key":"1379_CR39","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357\u20131361 (2010).","journal-title":"Nature"},{"key":"1379_CR40","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/glia.20572","volume":"55","author":"EA Zuiderwijk-Sick","year":"2007","unstructured":"Zuiderwijk-Sick, E. A. et al. Differentiation of primary adult microglia alters their response to TLR8-mediated activation but not their capacity as APC. Glia 55, 1589\u20131600 (2007).","journal-title":"Glia"},{"key":"1379_CR41","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.122.059062","volume":"147","author":"A Canfr\u00e1n-Duque","year":"2023","unstructured":"Canfr\u00e1n-Duque, A. et al. Macrophage-derived 25-hydroxycholesterol promotes vascular inflammation, atherogenesis, and lesion remodeling. Circulation 147, 388\u2013408 (2023).","journal-title":"Circulation"},{"key":"1379_CR42","doi-asserted-by":"crossref","first-page":"333ra350","DOI":"10.1126\/scitranslmed.aad6100","volume":"8","author":"S Zimmer","year":"2016","unstructured":"Zimmer, S. et al. Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming. Sci. Transl. Med. 8, 333ra350 (2016).","journal-title":"Sci. Transl. Med."},{"key":"1379_CR43","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1146\/annurev.biochem.78.072407.103859","volume":"78","author":"DW Russell","year":"2009","unstructured":"Russell, D. W., Halford, R. W., Ramirez, D. M., Shah, R. & Kotti, T. Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain. Annu. Rev. Biochem. 78, 1017\u20131040 (2009).","journal-title":"Annu. Rev. Biochem."},{"key":"1379_CR44","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1093\/brain\/awz174","volume":"142","author":"R Kacher","year":"2019","unstructured":"Kacher, R. et al. CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington\u2019s disease. Brain 142, 2432\u20132450 (2019).","journal-title":"Brain"},{"key":"1379_CR45","doi-asserted-by":"crossref","first-page":"11876","DOI":"10.1074\/jbc.M116.723577","volume":"291","author":"KW Anderson","year":"2016","unstructured":"Anderson, K. W. et al. Mapping of the allosteric site in cholesterol hydroxylase CYP46A1 for efavirenz, a drug that stimulates enzyme activity. J. Biol. Chem. 291, 11876\u201311886 (2016).","journal-title":"J. Biol. Chem."},{"key":"1379_CR46","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1038\/jcbfm.2015.179","volume":"35","author":"TR Doeppner","year":"2015","unstructured":"Doeppner, T. R. et al. The indirect NMDAR antagonist acamprosate induces postischemic neurologic recovery associated with sustained neuroprotection and neuroregeneration. J. Cereb. Blood Flow. Metab. 35, 2089\u20132097 (2015).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"1379_CR47","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.7150\/thno.84059","volume":"13","author":"W Xin","year":"2023","unstructured":"Xin, W. et al. Preconditioned extracellular vesicles from hypoxic microglia reduce poststroke AQP4 depolarization, disturbed cerebrospinal fluid flow, astrogliosis, and neuroinflammation. Theranostics 13, 4197\u20134216 (2023).","journal-title":"Theranostics"},{"key":"1379_CR48","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jvs.2008.01.038","volume":"48","author":"JH Rapp","year":"2008","unstructured":"Rapp, J. H., Hollenbeck, K. & Pan, X. M. An experimental model of lacunar infarction: embolization of microthrombi. J. Vasc. Surg. 48, 196\u2013200 (2008).","journal-title":"J. Vasc. Surg."},{"key":"1379_CR49","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neurobiolaging.2016.11.002","volume":"50","author":"P Venkat","year":"2017","unstructured":"Venkat, P. et al. White matter damage and glymphatic dysfunction in a model of vascular dementia in rats with no prior vascular pathologies. Neurobiol. Aging 50, 96\u2013106 (2017).","journal-title":"Neurobiol. Aging"},{"key":"1379_CR50","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41593-018-0090-8","volume":"21","author":"Y Huang","year":"2018","unstructured":"Huang, Y. et al. Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletion. Nat. Neurosci. 21, 530\u2013540 (2018).","journal-title":"Nat. Neurosci."},{"key":"1379_CR51","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1161\/hs1101.098367","volume":"32","author":"J Chen","year":"2001","unstructured":"Chen, J. et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32, 2682\u20132688 (2001).","journal-title":"Stroke"},{"key":"1379_CR52","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/STROKEAHA.116.015592","volume":"48","author":"X Cui","year":"2017","unstructured":"Cui, X. et al. ABCA1\/ApoE\/HDL pathway mediates GW3965-induced neurorestoration after stroke. Stroke 48, 459\u2013467 (2017).","journal-title":"Stroke"},{"key":"1379_CR53","volume":"4","author":"A Kaur","year":"2023","unstructured":"Kaur, A., Shuken, S., Yang, A. C. & Iram, T. A protocol for collection and infusion of cerebrospinal fluid in mice. STAR Protoc. 4, 102015 (2023).","journal-title":"STAR Protoc."},{"key":"1379_CR54","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2022.100323","volume":"64","author":"N El-Darzi","year":"2023","unstructured":"El-Darzi, N. et al. 2-Hydroxypropyl-\u03b2-cyclodextrin mitigates pathological changes in a mouse model of retinal cholesterol dyshomeostasis. J. Lipid Res. 64, 100323 (2023).","journal-title":"J. Lipid Res."},{"key":"1379_CR55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102876","volume":"59","author":"Y Baumer","year":"2020","unstructured":"Baumer, Y. et al. Hyperlipidaemia and IFNgamma\/TNFalpha synergism are associated with cholesterol crystal formation in endothelial cells partly through modulation of lysosomal pH and cholesterol homeostasis. EBioMedicine 59, 102876 (2020).","journal-title":"EBioMedicine"},{"key":"1379_CR56","first-page":"Ec12","volume":"10","author":"DP Anil","year":"2016","unstructured":"Anil, D. P., Sudhir, D. P., Saksena, A. & Khurana, N. An affordable, indigenous polarizer\u2013analyser system with inbuilt retardation plate function to detect birefringence using 3D glasses: an experience. J. Clin. Diagn. Res. 10, Ec12\u2013Ec14 (2016).","journal-title":"J. Clin. Diagn. Res."},{"key":"1379_CR57","doi-asserted-by":"crossref","unstructured":"Oliviero, F. & Punzi, L. in Synovial Fluid Analysis and The Evaluation of Patients With Arthritis (ed. Mandell, B. F.) 79\u201390 (Springer International, 2022).","DOI":"10.1007\/978-3-030-99612-3_9"},{"key":"1379_CR58","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1433227","volume":"11","author":"K Nishimiya","year":"2024","unstructured":"Nishimiya, K. et al. Imaging human coronary cholesterol\/urate crystals with cross-polarized micro-optical coherence tomography. Front. Cardiovasc. Med. 11, 1433227 (2024).","journal-title":"Front. Cardiovasc. Med."},{"key":"1379_CR59","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.immuni.2021.04.022","volume":"54","author":"L Shi","year":"2021","unstructured":"Shi, L. et al. Treg cell-derived osteopontin promotes microglia-mediated white matter repair after ischemic stroke. Immunity 54, 1527\u20131542.e8 (2021).","journal-title":"Immunity"},{"key":"1379_CR60","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1177\/0271678X20925655","volume":"40","author":"L Shi","year":"2020","unstructured":"Shi, L. et al. Genome-wide transcriptomic analysis of microglia reveals impaired responses in aged mice after cerebral ischemia. J. Cereb. Blood Flow. Metab. 40, S49\u2013s66 (2020).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"1379_CR61","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/s42255-024-01047-2","volume":"6","author":"Y Meng","year":"2024","unstructured":"Meng, Y. et al. Glycolytic enzyme PFKL governs lipolysis by promoting lipid droplet-mitochondria tethering to enhance \u03b2-oxidation and tumor cell proliferation. Nat. Metab. 6, 1092\u20131107 (2024).","journal-title":"Nat. Metab."}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01379-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01379-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01379-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T16:51:44Z","timestamp":1761324704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01379-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":61,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["1379"],"URL":"https:\/\/doi.org\/10.1038\/s42255-025-01379-7","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]},"assertion":[{"value":"15 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}